Mucoadhesive liposomal delivery systems: The choice of coating material

Drug Development and Industrial Pharmacy

Volumn 37, Issue 4, 2011, Pages 482-488

  Karn, Pankaj Ranjan ^a,b   Vanić, Zeljka ^c   Pepić, Ivan ^c   Škalko Basnet, Nataša ^a,d  

^a POKHARA UNIVERSITY   (Nepal)

^b Chungnam National University   (South Korea)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Atenolol; Carbopol; chitosan; Eudragit; liposomes; mucoadhesion; polymer coating

Indexed keywords

ALCOHOL; ATENOLOL; CARBOMER; CHITOSAN; EUDRAGIT; LIPOSOME; POLYMER;

ANIMAL TISSUE; ARTICLE; DRUG ABSORPTION; DRUG COATING; DRUG FORMULATION; IN VITRO STUDY; INTESTINE MUCOSA; LIPOSOMAL DELIVERY; MUCOADHESION; NONHUMAN; PARTICLE SIZE;

ATENOLOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; LIPOSOMES; PARTICLE SIZE; POLYMETHACRYLIC ACIDS; SOLUBILITY;

EID: 79953251460     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.523425     Document Type: Article

References (29)

1. Malik DK, Baboota S, Ahuja A, Hasan S, Ali J. (2007). Recent advances in protein and peptide drug delivery systems. Curr Drug Deliv, 4:141-51. (Pubitemid 46557490)
2. Stolnik S, Shakesheff K. (2009). Formulations for delivery of therapeutic proteins. Biotechnol Lett, 31:1-11.
3. Cui F, Qian F, Zhao Z, Yin L, Tang C, Yin C. (2009). Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. Biomacromolecules, 10:1253-58.
4. Andrews GP, Laverty TP, Jones DS. (2009). Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm, 71:505-18.
5. Takeuchi H, Yamamoto KY. (2001). Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev, 47:39-54. (Pubitemid 32209231)
6. Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y. (1996). Enteral absorption of insulin in rats from mucoadhesive chitosan coated liposomes. Pharm Res, 13:896-901. (Pubitemid 26227747)
7. Drummond DC, Noble CO, Hayes ME, Park JW, Kirpotin DB. (2008). Pharmacokinetics and in vivo release rates in liposomal nanocarrier development. J Pharm Sci, 97:4696-740.
8. Iwanaga K, Ono S, Narioka K, Kakemi M, Morimoto K, Yamashita S, et al. (1999). Application of surface-coated liposomes for oral delivery of peptide: Effects of coating the liposome's surface on the GI transit of insulin. J Pharm Sci, 88:248-52. (Pubitemid 29084739)
9. Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y. (2003). Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release, 86:235-42. (Pubitemid 36084273)
10. Filipovic-Grcic J, Skalko-Basnet N, Jalsenjak I. (2001). Mucoadhesive chitosan-coated liposomes: Characteristics and stability. J Microencapsul, 18:3-12. (Pubitemid 32058676)
11. Guo J, Ping Q, Jiang G, Huang L, Tong Y. (2003). Chitosan coated liposomes: Characterization and interaction with leuprolide. Int J Pharm, 260:167-73. (Pubitemid 36773915)
12. Mady MM, Darwish MM, Khalil S, Khalil WM. (2009). Biophysical studies on chitosan-coated liposomes. Eur Biophys J, 38:1127-33.
13. Werle M, Takeuchi H. (2009). Chitosan-aprotonin coated liposomes for oral peptide delivery: Development, characterization and in vivo evaluation. Int J Pharm, 370:26-32.
14. Muramatsu M, Kanada K, Nishida A, Ouchi K, Saito N, Yoshida M, et al. (2000). Application of Carbopol to controlled release preparations I. Carbopol as a novel coating material. Int J Pharm, 99:77-83. (Pubitemid 30224507)
15. Singla AK, Chawla M, Singh A. (2000). Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: A review. Drug Dev Ind Pharm, 26:913-24. (Pubitemid 30471037)
16. Kumar R, Gupta RB, Betageri GV. (2001). Formulation, characterization and in vitro release of glyburide from proliposomal beads. Drug Deliv, 8:25-7. (Pubitemid 32179160)
17. Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. (1992). In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm, 78:43-8.
18. Sogias IA, Williams AC, Khutoryanskiy VV. (2008). Why is chitosan mucoadhesive? Biomacromolecules, 9:1837-42.
19. Baloum M, Friedman DI, Rubinstein A. (1997). Absorption enhancement of calcitonin in the rat intestine by carbopol-containing submicron emulsions. Int J Pharm, 154:235-43. (Pubitemid 27351328)
20. Jain D, Majumdar DK, Panda AK. (2006). Insulin loaded Eudragit L100 microspheres for oral delivery: Preliminary in vitro studies. J Biomater Appl, 21:195-211. (Pubitemid 44848516)
21. Jain D, Panda AK, Majumdar DK. (2005). Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS Pharm- SciTech, 6:E100-7. (Pubitemid 41644139)
22. Galovic Rengel R, Barisic K, Pavelic Z, Zanic Grubisic T, Cepelak I, Filipovic-Grcic J. (2002). High efficiency entrapment of superoxidase dismutase into mucoadhesive chitosan-coated liposomes. Eur J Pharm Sci, 15:441-48.
23. de Abreu LRP, de Castro SAC, Pedrrazzoli J Jr. (2003). Atenolol quantification in human plasma by high-performance liquid chromatography: Application to bioequivalence study. AAPS PharmSci, 5:1-7.
24. Skalko N, Cajkovac M, Jalsenjak I. (1998). Liposomes with metronidazole for topical use: The choice of preparation method and vehicle. J Liposome Res, 8:283-93. (Pubitemid 28268268)
25. González-Rodríguez ML, Barros LB, Palma J, González- Rodríguez PL, Rabasco AM. (2007). Application of statistical experimental design to study the formulation variables influencing the coating process of lidocaine liposomes. Int J Pharm, 337:336-45. (Pubitemid 46778957)
26. Chowdary KPR, Rao YS. (2003). Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: A technical note. Mucoadhesive microsphere for controlled drug delivery. AAPS PharmSciTech, 4:1-6.
27. Takeuchi H, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. (2005). Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm, 303:160-70. (Pubitemid 41318033)
28. Wu Z, Ping Q, Lai J. (2004). Hypoglycemic efficacy of chitosan coated insulin liposomes after oral administration in mice. Acta Pharmacol Sin, 25:966-72. (Pubitemid 38915458)
29. Shende P, Gaud R. (2009). Formulation and comparative characterization of chitosan, gelatin and chitosan-gelatin-coated liposomes of CPT-11-HCl. Drug Dev Ind Pharm, 35:612-18.